During the past decade, Centro Hospitalar de Lisboa Central conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centro Hospitalar de Lisboa Central" #1 sponsor was "Janssen Research & Development, LLC" with 2 trials, followed by "Actelion" with 1 trials sponsored, "Boston Medical Center" with 1 trials sponsored, "ClinTrio Ltd." with 1 trials sponsored and "Hospital Clinic of Barcelona" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centro Hospitalar de Lisboa Central" #1 collaborator was "Centro Hospitalar de Lisboa Central" with 2 trials as a collaborator, "Brighton and Sussex University Hospitals NHS Trust" with 1 trials as a collaborator, "Centro Hospitalar Lisboa Ocidental" with 1 trials as a collaborator, "European Aids Treatment Group (EATG), Brussels, Belgium" with 1 trials as a collaborator and "Fundacion Clinic per a la Recerca Biomédica" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Centro Hospitalar de Lisboa Central" are "Urinary Bladder Neoplasms" (2 trials), "Acute Respiratory Failure" (1 trials), "Aneurysm, Brain" (1 trials), "HIV Infections" (1 trials) and "Hypertension Secondary" (1 trials). Many other conditions were trialed in "Centro Hospitalar de Lisboa Central" in a lesser frequency.

Most popular intervention types in "Centro Hospitalar de Lisboa Central" are "Drug" (3 trials), "Biological" (2 trials), "Other" (2 trials), "Procedure" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cetrelimab" (2 trials), "TAR-200" (2 trials), "Cisplatin" (1 trials), "Conventional laparoscopic Roux-en-Y gastric bypass" (1 trials) and "Conventional radiation therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centro Hospitalar de Lisboa Central" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Centro Hospitalar de Lisboa Central". undefined are not yet recruiting, 5 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Centro Hospitalar de Lisboa Central, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Centro Hospitalar de Lisboa Central, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".